期刊文献+

菊苣酸在HepG2细胞中对SOSC3表达的调节作用 被引量:3

The Regulation of SOCS3 by Chicoric Acid in HepG2 Cells
原文传递
导出
摘要 探讨菊苣酸(Chicoric acid,CRA)在人肝细胞系HepG2细胞中对细胞因子信号转导抑制分子3(Suppressor of cyto-kine signaling 3,SOCS3)表达的影响,用剂量为0、5和50μg.mL-1 CRA分别处理HepG2细胞24h后,经RT-PCR、Real-time PCR检测SOCS3基因的mRNA表达情况,再以上述不同剂量CRA分别处理细胞24h以及50μg.mL-1CRA分别处理HepG2细胞0、6、12、18和24h后,用Western blot法检测SOCS3基因的表达情况。研究结果显示CRA作用于HepG2细胞后,SOCS3基因的mRNA和蛋白表达水平随着CRA剂量增加而显著下降(p<0.01),且呈现一定的剂量依赖性;随着处理时间的增加,SOCS3蛋白表达水平下降更加明显,说明在翻译水平CRA不仅呈剂量依赖性,还呈时间依赖性下调SOCS3蛋白的表达。这些结果提示CRA可抑制SOCS3蛋白在HepG2细胞中的表达。 To understand the effect of chicoric acid on the expression of suppressor of cytokine signaling 3 (SCICS3) in human heptaocellular carcinoma (HCC) cell line HepG2, the present study investigated the relationship among the mRNA level, pro- tein expression of SOCS3 and chicoric acid concentration. Firstly, HepG2 was treated with a series of concentration of chicoric acid. Secondly, the SOCS3 mRNA was assayed by semi-quantitative RT-PCR and Real-time RT-PCR 24h later, and the ex- pression of SOCS3 protein was assayed using Western Blot technique. And then, total protein expression of SOCS3 in HepG2 treated with different time(0,6,12,18,24 h)of ehieorie acid was analyzed using Western Blot. The results showed that, com- pared with control group, both of mRNA and protein expression of SOCS3 in HepG2 cells decreased significantly with the in- creasing concentration of chicoric acid in a dose-dependent manner (p^0.01). Moreover, with the increase of manipulation time, the protein expression of SOCS3 in HepG2 cells was found to be down regulated significantly by chicoric acid in a dose- and time-dependent way. Therefore, this study shows that the chicoric acid can down regulate the expression of SOCS3 in HepG2 cells.
出处 《重庆师范大学学报(自然科学版)》 CAS 北大核心 2012年第6期75-79,共5页 Journal of Chongqing Normal University:Natural Science
基金 国家自然科学基金(No.81001302 No.31071968)
关键词 菊苣酸 细胞因子信号转导抑制分子3(SOCS3) HEPG2细胞 胰岛素抵抗 chicoric acid suppressor of cytokine signaling (SOCS3) HepG2 cells insulin resistance
  • 相关文献

参考文献17

  • 1Croker B A,Kiu H,Nicholson S E. SOCS regulation of the JAK/STAT signalling pathway [J].Semin Cell Dev Biol,2008,19(4) :414-422.
  • 2Serrano-Marco L,Rodriguez-Calvo R,E1 Kochairl, et al. Activation of peroxisome proliferator-activated receptoβ/-δ(PPAR-β/-δ) ameliorates insulin signaling and re duces SOCS3 levels by inhibiting STAT3 in interleukin- 6-stimulated adiposities[J]. Diabetes,2011,60(7) : 1990- 1999.
  • 3Panveloski-Costa A C,Pinto Jfinior D A,Brandao B B,et al. Resistive training reduces inflammation in skeletal muscle and improves the peripheral insulin sensitivity in obese rats induced by hyperlipidic diet [J]. Arq Bras En- doerinol Metabol,2011,55(2) : 155-163.
  • 4Emanuelli B,Peraldi P,Filloux C,et al. SOCS-3 is an in- sulin- induced negative regulator of insulin signaling [J]. J Biol Chem,2000,275(21) :15985-15991.
  • 5Lubis A R,Widia F,Soegondo S,et al. The role of SOCS- 3 protein in leptin resistance and obesity [J]. Acta Med Indones,2008,40(2) :89-95.
  • 6Yang S J,Xu C Q,Wu J W,et al. SOCS3 inhibits insulin signaling in porcine primary adipocytes [J]. Mol Cell Biochem, 2010,345 (1/2) :45-52.
  • 7Rui L, Yuan M, Frantz D, et al. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2[J].J Biol Chem, 2002,277(44): 42394- 42398.
  • 8Story D J, Stephens J M. Modulation and lack of cross- talk between signal transducer and activator of transcrip- tion 5 and suppressor of eytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes[J]. Obesity (Silver Spring), 2006,14(8) : 1303-1311.
  • 9Mcgillicuddy F C, Chiquoine E H, Hinkle C C, et al. In terferon gamma attenuates insulin signaling, lipid stor- age,and differentiation in human adipocytes via activa- tion of the JAK/STAT pathway [J]. Biol Chem, 2009, 284(46) :31936-31944.
  • 10Tousch D, Laioix A D, Hosy E, et al. Chicoric acid, a new compound able to enhance insulin release and glu- cose uptake [J].Biochem Biophys Res Commun,2008,377(1):131-135.

同被引文献44

  • 1钱程,于益芝.创新与联合:肿瘤免疫细胞因子综合治疗的最佳组合的迭代与探索[J].中国肿瘤生物治疗杂志,2022,29(3):167-174. 被引量:1
  • 2刘晓琳,郭世宁,黎建华,刘汉儒,吴鸿.紫锥菊的药理作用和临床应用[J].黑龙江畜牧兽医,2007(6):83-85. 被引量:12
  • 3胡建平,常珊,陈慰祖,王存新.HIV-1整合酶与抑制剂LCA的结合模式及抗药性研究[J].中国科学(B辑),2007,37(3):279-287. 被引量:3
  • 4LIM T K. Echinacea purpurea, edible medicinal and non-medicinal plants[M]. Berlin: Springer Netherlands, 2014: 340-371.
  • 5ZHANG Hongli, DAI Linghao, WU Yihang, et al. Evaluation of hepatocyteprotective and anti-hepatitis B virus properties of cichoric acid from Cichorium intybus leaves in cell culture[J]. Biological and Pharmaceutical Bulletin, 2014, 37(7): 1214-1220.
  • 6THYGESEN L, THULIN J, MORTENSEN A, et al. Antioxidant activity of cichoric acid and alkamides from Echinacea purpurea, alone and in combination[J]. Food Chemistry, 2007, 101(1): 74-81.
  • 7DALBY B L, BARSETT H, LANDBO A K R, et al. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins[J]. Journal of Agricultural and Food Chemistry, 2005, 53(24): 9413-9423.
  • 8SOICKE H, HASSAN G, GORLER K, et al. Further derivatives of caffeic acid from Echinacea purpurea[J]. Planta Medica, 1988, 54(2): 175-176.
  • 9ROBINSON J E. L-chicoric acid, an inhibitor of human immunodeficiency virus type I (HIV-1) integrase, improves on the in vitro anti-HIV-I effect of zidovudine plus a protease inhibitor (AGI350)[J]. Antiviral Research, 1998, 39(2): 101-111.
  • 10LIN Zhaiwei, NEAMATI N, ZHAO He, et al. Chicoric acid analogues as HIV-I integrase inhibitors[J]. Journal of Medicinal Chemistry, 1999, 42(8): 1401-1414.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部